J JAY LOBELL
CIK 1172659 · CEO and Secretary · last filed 2026-01-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.76M
Companies
5
Total Filings
53
Lifetime Open-Market Net
$488.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FBIOP | Director | 192,397 | $18.76 | $3.61M | $250.0K | 10 | 2026-01-05 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | 0 | $2.16 | $0 | $0 | 5 | 2023-08-31 |
| FBIO | Director | 45,733 | $3.39 | $155.0K | $0 | 2 | 2017-01-24 |
| Fortress Biotech, Inc. (CNDO) Delisted | Director | 486,000 | — | — | $238.1K | 8 | 2015-03-16 |
| NVD | Director | — | $5.22 | — | $0 | 2 | 2008-12-30 |
Recent Filings · Page 3 of 6
53 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-08-22 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +5,000 | $36.9K | EDGAR |
| 2013-06-21 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +10,000 | $76.2K | EDGAR |
| 2013-02-11 | Fortress Biotech, Inc. (CNDO) Delisted | Mixed | — | $0 | EDGAR |
| 2012-06-26 | Fortress Biotech, Inc. (CNDO) Delisted | Buy (P) | +25,000 | $125.0K | EDGAR |
| 2012-02-14 | Fortress Biotech, Inc. (CNDO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-11-17 | — | Other (J) | — | $0 | |
| 2009-01-21 | — | Grant (A) | +10,964 | $0 | |
| 2008-12-30 | NVD | Grant (A) | — | $0 | EDGAR |
| 2008-10-20 | — | Grant (A) | +1,016 | $0 | |
| 2008-09-23 | — | Mixed | +25,252 | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.